According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 percent) of all deaths in the UK, which equates to more than 160,000 deaths each year — or one death every three minutes.

Getty Images


May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 percent) of all deaths in the UK, which equates to more than 160,000 deaths each year — or one death every three minutes.

The research, published in the top science journal Advanced Science, found that injection of the trace mineral manganese could enhance MRI scans so that they provided more accurate details of heart function than traditional MRI methods.

These findings, if confirmed in human subjects, could have major implications for the treatment of heart attack patients. The findings could also be of great use in the preclinical evaluation of treatments for patients who suffer from cardiac ischemia — a reduction in blood supply to the heart muscle that could lead to cardiac arrest.

The study also suggests that if manganese-enhanced MRI is performed within the first few hours of a heart attack it could be used to determine the optimal treatment regime for individual patients — helping to regulate changes in the cardiac muscle and thereby further improving survival chances. Findings were evaluated by examining the infarct size and blood supply at three key intervals: one hour, one day and 14 days after a myocardial infarction was induced.

Patrizia Camelliti, M.D., Principal Investigator and Senior Lecturer in Cardiovascular Science at the University of Surrey, said: "Magnetic resonance imaging (MRI) is increasingly used to diagnose and give information on heart conditions. This research using mice allows us to measure the health status of the heart muscle rapidly after a heart attack and could provide important information for optimising treatments in patients."

For more information: http://www.surrey.ac.uk


Additional Content

News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Lung Imaging

Nov.2, 2026 – SimonMed has announced the clinical launch of two advanced lung imaging technologies, CT:VQ and LDAf, in ...

Time November 02, 2026
arrow
News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Oct. 26, 2026 — Dr. Kathryn Keenan is one of seven public servants from various federal agencies who will be honored at ...

Time October 27, 2026
arrow
News | Radiology Business

Oct. 26, 2026 — RadNet, Inc. has entered into a definitive agreement to acquire ONRAD, Inc., a provider of teleradiology ...

Time October 27, 2026
arrow
Subscribe Now